Effect of dexmedetomidine on pulmonary function in obese patients undergoing laparoscopic surgery

Huan Chen; Xin Wang; Yawen Zhang; Wei Liu; Changhao Zhou; Deli Zheng

doi:10.1186/s13741-024-00396-6

Effect of dexmedetomidine on pulmonary function in obese patients undergoing laparoscopic surgery

Perioper Med (Lond). 2024 May 16;13(1):42. doi: 10.1186/s13741-024-00396-6.

Authors

Huan Chen¹, Xin Wang¹, Yawen Zhang¹, Wei Liu¹, Changhao Zhou¹, Deli Zheng²

Affiliations

¹ Department of Anesthesiology, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China.
² Department of Anesthesiology, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China. gendly2023@163.com.

Abstract

Objective: This research aimed to ascertain the effect of dexmedetomidine on pulmonary function in obese patients undergoing laparoscopic surgery.

Methods: Obese patients undergoing laparoscopic surgery under general anesthesia were separated into the control group (group C) and the dexmedetomidine group (group D) (n = 30). Patients in group D were infused with dexmedetomidine (1 μg/kg) intravenously for 10 min and then at a rate of 0.5 mg/kg h until 30 min before the end of the surgery, and those in group C were infused with an equal volume of saline. The surgery time points were divided into: before anesthesia induction (T0), 5 min after intubation (T1), 30 min after pneumoperitoneum (T2), 10 min after pneumoperitoneum release (T3), at the time of extubation (T4), 3 min after extubation (T5), and 24 h after surgery (T6). Arterial blood was collected for blood gas analysis to record arterial partial pressure of oxygen (PaO₂) and arterial partial pressure of carbon dioxide (PaCO₂). Dynamic lung compliance (Cdyn), oxygenation index (OI), alveolar-arterial oxygen partial pressure difference (A-aDO₂), and respiratory index (RI) were calculated. The time of surgery, anesthesia, CO₂ pneumoperitoneum, eye-opening, and time from the end of surgery to extubation were recorded. Plasma IL-8 and IL-10 levels were measured from T0 to T6.

Results: The time of surgery, anesthesia, CO₂ pneumoperitoneum, eye-opening, and time from the end of surgery to extubation in group D were not statistically significant when compared with those in group C. Versus at the T1 time point, A-aDO₂ and RI were higher and Cdyn and OI were lower in both groups at T2 and T3 time points. Versus group C, group D had higher Cdyn and OI and lower A-aDO₂ and RI at T2 and T3 time points. Versus at the T0 time point, at each time point from T1 to T6, IL-8 and IL-10 levels were higher in both groups. Versus group C, group D had lower IL-8 and higher IL-10 levels at each time point from T1 to T6.

Conclusion: In obese patients undergoing laparoscopic surgery under general anesthesia, the use of dexmedetomidine can improve the lung compliance and OI of the patients, inhibit the inflammatory response of the lungs of the patients and thus have a certain protective effect on the lung function.

Keywords: Dexmedetomidine; General anesthesia; Inflammatory markers; Laparoscopy; Lung protection; Obesity.

Abstract

Grants and funding